EUR 115.88 For Business Accounts Only

FDA Office of Orphan Products Development - Company Review

FDA Office of Orphan Products Development - Company Review

Summary

FDA Office of Orphan Products Development (OOPD), a subsidiary of US Food and Drug Administration is a government organization that evaluates and develops products such as drugs, biologics, devices, and medical foods for the diagnosis and treatment of rare diseases. The organization offers solutions for rare disease with the medical and research communities, professional organizations, academia, governmental agencies, industry and rare disease patient groups. OOPD offers incentives for sponsors to develop products for rare conditions. The organization’s programs include orphan drug designation program, humanitarian use device (HUD) program and orphan products grants program. OOPD is headquartered in Silver Spring, Maryland, the US.

This comprehensive company report of FDA Office of Orphan Products Development provides you with company's businesses and operations information.

The profile contains critical company information including,

- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.